ストックスクリーナーアプリを入手
6.34
7.64%
0.45
前日終値:
$5.89
開ける：
$6.34
24時間の取引高:
323
Relative Volume:
0.07
時価総額：
$8.03M
収益：
$204.80K
当期純損益:
$-8.27M
株価収益率:
-0.6969
EPS:
-9.097
ネットキャッシュフロー:
$-2.63M
1週間 パフォーマンス:
+9.50%
1か月 パフォーマンス:
-2.46%
6か月 パフォーマンス:
-18.72%
1年 パフォーマンス:
-29.08%
1日の値動き範囲:
$6.34
$6.34
1週間の範囲:
$5.89
$6.34
52週間の値動き範囲:
$5.41
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Compare ADXN vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
6.34 | 8.03M | 204.80K | -8.27M | -2.63M | -9.097 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-31 | アップグレード | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr (ADXN) 最新ニュース
Addex Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:ADXN) - TradingView
Enterprise value to revenue forward of Addex Therapeutics Ltd Sponsored ADR – LSX:A3EXC6 - TradingView
Price to earnings forward of Addex Therapeutics Ltd Sponsored ADR – LSX:A3EXC6 - TradingView
Price to sales forward of Addex Therapeutics Ltd Sponsored ADR – LSX:A3EXC6 - TradingView
Earnings call transcript: Addex Therapeutics trims loss in Q1 2026 as cash burn stays low - Investing.com India
Addex Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat
Press Release: Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Moomoo
ADXNAddex Therapeutics Ltd ADR Stock Price and Quote - Finviz
Addex Therapeutics (NASDAQ: ADXN) flags tight cash runway and heavy partner reliance - Stock Titan
Addex Therapeutics H2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Addex Therapeutics H2 2026 reveals strategic shifts By Investing.com - Investing.com India
Earnings call transcript: Addex Therapeutics H2 2026 reveals strategic shifts - Investing.com
Addex Therapeutics announces GABAB PAM candidate data - TipRanks
Addex Therapeutics says spin-out company to complete NTX-253 study in Q2 - TipRanks
Addex Therapeutics Short Interest Drops in March - National Today
JX Luxventure Group Inc (NASDAQ:JXG) Short Interest Up 140.3% in February - Defense World
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8% - Defense World
SPDR SSgA Multi-Asset Real Return ETF (NYSEARCA:RLY) Short Interest Up 142.0% in February - Defense World
Short Interest in Intrum AB (publ) (OTCMKTS:ITJTY) Grows By 140.2% - Defense World
Breakwave Tanker Shipping ETF (NYSEARCA:BWET) Short Interest Update - Defense World
Solidion Technology Inc. (NASDAQ:STI) Sees Significant Growth in Short Interest - Defense World
Addex Therapeutics (NASDAQ:ADXN) Trading 2% Higher – Here’s Why - Defense World
Addex publishes negative allosteric modulators data in Molecular Psychiatry - TipRanks
CGX Energy (CVE:OYL) Shares Up 17.2% – Should You Buy? - Defense World
FedEx Corporation $FDX Shares Purchased by Transcend Capital Advisors LLC - Defense World
Orex Minerals (CVE:REX) Shares Down 22.8% – What’s Next? - Defense World
Paycom Software (NYSE:PAYC) Price Target Lowered to $210.00 at UBS Group - Defense World
Addex Therapeutics (ADXN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - The Globe and Mail
Addex Therapeutics Reports Q3 2025 Financial Results - The Globe and Mail
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - The Globe and Mail
ADXN SEC FilingsAddex Therapeutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Addex Therapeutics Ltd_December 31, 2024 - SEC.gov
Aspire Biopharma (ASBP) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Get insights into the top gainers and losers of Monday's pre-market session. - ChartMill
Which stocks are moving after the closing bell on Tuesday? - ChartMill
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2026 - MarketBeat
Barinthus Biotherapeutics plc (BRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - CNN
Psyence Biomedical (PBM) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
60 Degrees Pharmaceuticals (SXTP) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Thursday's pre-market session: top gainers and losers - ChartMill
Most VolatileStock ScreenerNews - Finviz
Ernexa Therapeutics (ERNA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Which stocks are moving after the closing bell on Friday? - ChartMill
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Gapping stocks in Tuesday's session - ChartMill
Which stocks are moving before the opening bell on Tuesday? - ChartMill
Trading Halts Explained - MarketBeat
Addex Therapeutics Ltd Adr (ADXN) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):